Microrheology properties of erythrocytes in patients with arterial hypertension and dyslipidemia taking rosuvastatin

Objective – identify features of erythrocyte rheological properties in patients with arterial hypertension with dyslipidemia, receiving rosuvastatin. Under the supervision of 30 patients with arterial hypertension were 1–2 degree with dyslipidemia type IIb 3 risk. The monitoring group comprised 26 healthy people of similar age. In patients taking rosuvastatin, highlighted the positive dynamics of lipid composition covers plasma and erythrocyte with normalization through 16 weeks observation. While therapy achieved growth of antioxidant protection of blood plasma, erythrocytes and lipid peroxidation in them achieving the normalization of cellular composition and aggregation of erythrocytes after 16 weeks therapy that point to minimize their risk of blood clot formation.